[LIVER] Liver Toxicity Testing

Drug-Induced Liver Injury (DILI) Prediction System

87%
DILI Prediction Accuracy
30%
Drug Failures Prevented
$2B
Annual Savings Potential

Drug Compound Selection

Exposure Parameters

Test Protocols

Hepatotoxicity Assessment

DILI Risk Score
--
Hepatocyte Viability
100%
ALT/AST Elevation
Normal
Mitochondrial Function
Optimal
Bile Acid Transport
Normal

Learn More About Liver-on-Chip Testing

This simulation demonstrates how liver-on-chip technology predicts drug-induced liver injury (DILI) with 87% accuracy compared to 43% for animal models. In September 2024, Emulate's Liver-Chip S1 became the first organ-on-chip to receive FDA ISTAND acceptance.

Organ-on-Chip Guide FDA Modernization Act Scientific Evidence Learning Paths

© 2025 Patient Analog. All rights reserved.

Educational content created by J Radler for the biotech and scientific community. Last updated: February 4, 2026.

Free to share for educational purposes with attribution.

FDA Modernization Act 3.0 Educational Resource

Patient Analog is a comprehensive biotech education platform. For licensing inquiries: contact form

This educational resource is provided to advance understanding of human-relevant medicine and FDA Modernization Act 3.0. Content may be shared with proper attribution to Patient Analog.